Great news for 340B hospitals impacted by the reimbursement reductions initiated by the Center for Medicare and Medicaid Services (CMS) on January 1, 2018. Recently, CMS announced that the 2023 Medicare outpatient payment rates will be restored to rates prior to 2018 for affected hospitals. After many legal debates, court filings, and outcry from hospitals […]
Read More
In June, the Supreme Court gave hospitals participating in the 340B Drug Pricing Program a convincing victory ruling unanimously that the U.S. Center for Medicare & Medicaid Services (CMS) should not have reduced reimbursement for covered outpatient prescription drugs purchased by those hospitals. 340B Hospitals Challenge Payment Rates Hospitals challenged the 2018 and 2019 payment […]
Read More
Great news for 340B Hospitals affected by COVID-19. On March 15, 2022, President Biden signed into law the $1.5 trillion Consolidated Appropriations Acts, 2022. This bill allows Hospitals that have lost eligibility due to a decrease in their Medicare disproportionate share (DSH) percentage as a result of the COVID-19 public health emergency to regain access […]
Read More
The 340B Program has seen a lot of changes in 2021. Join Blue & Co.’s Apexus Advanced 340B Experts for a webinar on Thursday, July 15 at 12:00 p.m. In this webinar, Jason Prokopik and Chad Downing will be covering some of the current 340B trends and provide updates from recent HRSA Audits that may […]
Read More
After months of pharmaceutical manufacturers placing restrictions on the 340B Program to both contract pharmacies and covered entities, HRSA sent letters to six pharmaceutical manufacturers stating they violated the 340B Statute. The HRSA Acting Administrator declared these pharmaceutical manufacturers violated the 340B statue by placing restrictions on the 340B Program pricing at both contract pharmacy […]
Read More
Over the past year, there have been many changes within the 340B Program. Join Jason Prokopik from Blue & Co., LLC and Wes Butler from Barnett Benvenuti & Butler on Tuesday, February 9 from noon to 1 p.m. EST as they discuss how the recent political changes could impact the 340B Program and what it […]
Read More
On December 27, 2020, President Trump signed into law the Consolidated Appropriations Act (CAA), 2021. Included in this bill are comprehensive Rural Health Clinic reimbursement changes and provide possible new opportunities for both RHCs and hospitals. Rural Health Clinic Medicare Rates The most significant change included in the CAA was made to the RHC Medicare rates. […]
Read More
Blue & Co., LLC is excited to announce it has recently expanded its pharmacy and 340B expertise to meet and exceed the needs of its clients. With the addition of multiple pharmacy staff members in 2020, Blue is positioned to provide a wide array of pharmacy consulting services to healthcare organizations looking for guidance. About […]
Read More
The 2021 Grantee 340B Recertification period for Consolidated Health Centers, Federal Qualified Health Center Look-Alikes, Ryan White, Comprehensive Hemophilia Treatment Centers, Native Hawaiian, Black Lung Programs, Urban Indian, and Tribal Compact 638 will be February 1 – March 1, 2021. A separate email will be sent out by HRSA with all of the information required […]
Read More
With current attacks on the 340B Program by some pharmaceutical manufacturers and other challenges affecting patients in need of prescription drugs, is it time for your Hospital or Health Center to consider a retail pharmacy strategy of its own? Some Hospitals and Health Centers own retail pharmacies, but opportunity still exists to improve the patient […]
Read More
Trusted Insights from The National Bank of Indianapolis Nonprofit Services Team Not-for-profit organizations are increasingly falling victim to fraud, with a rising number of incidents and an ever-growing amount of money being lost. Fraudsters find it easy to target not-for-profits, as their publicly available 990s provide valuable information. Protecting your organization from such fraudulent activities […]
Rising interest rates and historic inflation are impacting hospital purchasing decisions. Using capital efficiency concepts in making hospital purchasing plans is as important as ever. What is Capital Efficiency? Capital efficiency refers to how effectively a hospital deploys its resources to generate returns. In the context of fixed assets and software purchases, capital efficiency involves […]
By Amy Sandlin, CPA, Tax Senior Manager at Blue & Co. A pass-through entity tax proposal is currently making its way through the Kentucky General Assembly as part of a larger tax omnibus bill (Kentucky House Bill 360). The pass-through entity (PTE) tax provisions in the bill are intended to be retroactive to January 1, […]
